Moderna Stocks Surged after US FDA Backed its Booster Shots

Stocks of Moderna Inc. surged on Thursday trading as the US Food and Drug Administration (FDA) supported the emergency use authorization of its booster shots.

The biotech company rocketed 3.23% or 10.38 points to $331.88 per share. Then, it also edged up 0.77% or 2.57 points to $334.45 per share on the after-hours trading. 

Accordingly, Moderna is one of the pioneers in messenger RNA (mRNA) therapeutics and vaccines. 

Last Thursday, the FDA advisory committee unanimously approved the authorization of Moderna’s mRNA-1273 booster at the 50.00 µg dose level. 

The approval details mirrored the agreements given to Pfizer and BioNTech vaccine last month. 

In addition, they recommended the vaccine shots specifically to individuals aged 65 and above as well as those aged 18 to 64 at high risk of severe diseases.

Consequently, the specified group must have at least six months after completion of the primary series. 

Moreover, the non-binding recommendation is a significant step to widening the booster campaign to millions of US citizens.  

Then, the vaccine rollout will only begin after the Centers for Disease Control and Prevention’s meeting on October 20.

Moreover, Moderna projected that the boosters could result in 1.00 billion supplementary doses available for distribution in 2022.

Last August, Moderna announced the approval of its third dose at a 100 µg level for immunocompromised individuals who are 18 years of age or older.

Subsequently, Pfizer Inc. hiked 0.63% or 0.26 points to $41.67 per share. 

At the same time, BioNTech SE rose 0.37% or 0.93 points to $250.33 per share. 

Then, Johnson & Johnson jumped 0.60% or 0.95 points to $160.11 per share as the approval of its booster shots was still on the horizon. 

Wall Street Rallied as Moderna Climbed

Meanwhile, the benchmark S&P 500 made its most extensive move since March as it climbed 1.71% or 74.46 points to 4,438.26 per share. 

Remarkably, highly-valued investment banking companies boosted the index as they beat their quarterly estimates. 

In particular, the Bank of America Corp. surged 4.52% or 1.95 points to $45.07 per share. 

Similarly, Citigroup Inc. soared 0.75% or 0.53 points to $70.80 per share. 

Correspondingly, the Dow Jones Industrial Average index boosted 1.56% or 534.75 points to $34,912.56 per share. 

Its top performer Walgreens Boots Alliance hiked 7.43% or 3.51 points to $50.77 per share. 

Consequently, the Nasdaq Composite index amplified 1.73% or 251.79 points to $14,823.43 per share. 

Then, technological stocks also posted gains as Moderna improved. 

For instance, Microsoft Corp. increased 2.17% or 6.44 points to $302.75 per share. 

Furthermore, Apple Inc. elevated 2.02% or 2.85 points to $143.76 per share. 

Read also: ProfitiX review | Should you choose ProfitiX?